What does VIVALAB do?

VIVALAB is a healthcare practice in Arlon. Private Limited, started on 8 October 1993, 1 establishment.

What is the address of VIVALAB?

The registered office of VIVALAB is located at Frassem, chemin du Glissisbour 5, 6700 Arlon.

Is VIVALAB still active?

Yes. According to the CBE (29 October 2026) VIVALAB is active, legal situation “Normale toestand”, started on 8 October 1993.

Is VIVALAB registered on Peppol?

Yes, VIVALAB is registered on the Peppol network with ID 0208:0451073259.

What is the enterprise number of VIVALAB?

The enterprise number of VIVALAB is BE0451073259.

When was VIVALAB founded?

VIVALAB was founded on 8 October 1993.

Who are the directors of VIVALAB?

According to the 2025 annual accounts, the directors of VIVALAB are: Jean-François CLASSEN, Frédéric GRANDJEAN.

Is VIVALAB a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 October 1993; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did VIVALAB make in 2025?

VIVALAB posted a profit after taxes of € 274 in financial year 2025.

What is the revenue of VIVALAB?

As a small company, VIVALAB is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 180,178.

How much does an employee at VIVALAB earn?

The average wage cost per full-time employee at VIVALAB was € 66,300 in 2025: staff costs of € 172,408 for 2.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does VIVALAB have?

According to the 2025 annual accounts, VIVALAB has 2.6 full-time equivalents (FTE).

VIVALAB (Private Limited) - Arlon - BE0451073259

Dossier VIVALAB, printed on 29 October 2026 from databakkes.be/en/0451073259/vivalab. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 12 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

VIVALAB from Arlon, company number BE0451073259, closed financial year 2025 with a result of € 274 after tax. For that financial year VIVALAB recorded a gross margin of € 180,178 and equity of € 6,197. Compared with financial year 2024, the result moved from € 0 to € 274. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 21, 2026.

What it is worth Healthy

€ 6,197

▼ 30% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 274

Profit after tax over the fiscal year.

Cash in the bank

€ 308,703

▼ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 2,902 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

2.6

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 172,408

▲ 3% vs 2024

€ 66,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 44,645

▼ 17% vs 2024

€ 9,678 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 159,448

▼ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 14,919

▼ 61% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 174,019 Gross margin 2022: € 174,019 First fiscal year in the series	€ 194,418 Gross margin 2023: € 194,418 ▲ 12% vs 2022 (€ 174,019) Favourable step	€ 190,781 Gross margin 2024: € 190,781 ▼ 2% vs 2023 (€ 194,418) Unfavourable step	€ 180,178 Gross margin 2025: € 180,178 ▼ 6% vs 2024 (€ 190,781) Unfavourable step	▼ 6%
Profit after taxes	€ 16 Profit after taxes 2022: € 16 First fiscal year in the series	€ -6 Profit after taxes 2023: € -6 ▼ € 22 vs 2022 (€ 16) Unfavourable step	€ 0 Profit after taxes 2024: € 0 ▲ € 6 vs 2023 (€ -6) Favourable step	€ 274 Profit after taxes 2025: € 274 Unchanged (€ 0) Favourable step
Equity	€ 9,356 Equity 2022: € 9,356 First fiscal year in the series	€ 9,350 Equity 2023: € 9,350 Unchanged (€ 9,356) Unfavourable step	€ 8,826 Equity 2024: € 8,826 ▼ 6% vs 2023 (€ 9,350) Unfavourable step	€ 6,197 Equity 2025: € 6,197 ▼ 30% vs 2024 (€ 8,826) Unfavourable step	▼ 30%
Total debts	€ 437,231 Total debts 2022: € 437,231 First fiscal year in the series	€ 532,346 Total debts 2023: € 532,346 ▲ 22% vs 2022 (€ 437,231) Unfavourable step	€ 2,754,052 Total debts 2024: € 2,754,052 ▲ € 2.2 million vs 2023 (€ 532,346) Unfavourable step	€ 2,845,566 Total debts 2025: € 2,845,566 ▲ 3% vs 2024 (€ 2,754,052) Unfavourable step	▲ 3%
Cash	€ 387,414 Cash 2022: € 387,414 First fiscal year in the series	€ 392,520 Cash 2023: € 392,520 ▲ 1% vs 2022 (€ 387,414) Favourable step	€ 457,224 Cash 2024: € 457,224 ▲ 16% vs 2023 (€ 392,520) Favourable step	€ 308,703 Cash 2025: € 308,703 ▼ 32% vs 2024 (€ 457,224) Unfavourable step	▼ 32%
Retained profit	€ 3,159 Retained profit 2022: € 3,159 First fiscal year in the series	€ 3,153 Retained profit 2023: € 3,153 Unchanged (€ 3,159) Unfavourable step	€ 2,628 Retained profit 2024: € 2,628 ▼ 17% vs 2023 (€ 3,153) Unfavourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 2,628) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 2,902 Dividend 2025: € 2,902 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 53,971 Bank debt 2024: € 53,971 Unchanged (€ 0) Unfavourable step	€ 44,645 Bank debt 2025: € 44,645 ▼ 17% vs 2024 (€ 53,971) Favourable step	▼ 17%
Balance sheet total	€ 446,587 Balance sheet total 2022: € 446,587 First fiscal year in the series	€ 541,696 Balance sheet total 2023: € 541,696 ▲ 21% vs 2022 (€ 446,587) Unchanged	€ 2,762,878 Balance sheet total 2024: € 2,762,878 ▲ € 2.2 million vs 2023 (€ 541,696) Unchanged	€ 2,851,763 Balance sheet total 2025: € 2,851,763 ▲ 3% vs 2024 (€ 2,762,878) Unchanged	▲ 3%
Employees (FTE)	2.6 Employees (FTE) 2022: 2.6 First fiscal year in the series	2.7 Employees (FTE) 2023: 2.7 ▲ 0.1 vs 2022 (2.6) Unchanged	2.6 Employees (FTE) 2024: 2.6 ▼ 0.1 vs 2023 (2.7) Unchanged	2.6 Employees (FTE) 2025: 2.6 Unchanged (2.6) Unchanged

Key figures of VIVALAB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VIVALAB?

What happened at VIVALAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 21, 2026 New annual accounts for financial year 2025: profit of € 274. Source: NBB ↗
2025 Jean-François CLASSEN became a director. NBB
2024 Frédéric GRANDJEAN became a director. NBB
Oct 8, 1993 New establishment in Arlon. KBO
Oct 8, 1993 Start of the company according to the CBE. KBO

In short

From € 16 profit in 2022 to € 274 profit in 2025.

Paid € 36,558 in corporate taxes since 2022.

Best year ever: 2025, with € 274 profit.

On average € 69,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Jean-François CLASSEN Frédéric GRANDJEAN

VIVALAB

Association des Médecins exercant dans les établissements de soins médicaux de VIVALIA, sites Arlon-Virton

FG LAB

Behind VIVALAB are Jean-François CLASSEN and Frédéric GRANDJEAN. Frédéric GRANDJEAN is also behind Association des Médecins exercant dans les établissements de soins médicaux de VIVALIA, sites Arlon-Virton and FG LAB.

Directors

According to the 2025 annual accounts

Jean-François CLASSEN

Director

since 2025

Frédéric GRANDJEAN

Director

Also active at: Association des Médecins exercant dans les établissements de soins médicaux de VIVALIA, sites Arlon-Virton, FG LAB

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Frassem, chemin du Glissisbour 5

6700 Arlon

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Laboratoire Classen

€ 185,395 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0451.073.259

VAT number

BE 0451.073.259

Registered office

Frassem, chemin du Glissisbour 5, 6700 Arlon

Names & denominations

VIVALAB

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

8 October 1993

Peppol

Active · Active since 5 Dec 2025

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

VIVALAB

Warning lights

Financials

What happened to VIVALAB?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions